MedinCell SA (MDCLF) Financial Statements
MedinCell SA Financial Overview
MedinCell SA's market cap is currently $1.06B. The company's EPS TTM is $-0.91; its P/E ratio is -28.97; MedinCell SA is estimated to report earnings on December 9, 2026, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 19.52M | $ 25.54M | $ 9.16M | $ 9.94M | $ 4.09M |
| Gross Profit | $ 19.52M | $ 25.54M | $ 9.16M | $ 9.94M | $ 4.09M |
| Operating Income | $ -25.50M | $ -10.84M | $ -20.98M | $ -24.02M | $ -23.81M |
| EBITDA | $ -23.67M | $ -11.20M | $ -18.61M | $ -26.41M | $ -21.45M |
| Net Income | $ -31.29M | $ -18.44M | $ -25.04M | $ -32.01M | $ -24.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 84.82M | $ 71.90M | $ 19.46M | $ 6.47M | $ 26.59M |
| Total Assets | $ 108.05M | $ 90.45M | $ 36.95M | $ 29.34M | $ 44.30M |
| Total Debt | $ 57.41M | $ 58.76M | $ 58.96M | $ 57.71M | $ 47.49M |
| Net Debt | $ -5.38M | $ -284.00K | $ 39.50M | $ 51.24M | $ 22.88M |
| Total Liabilities | $ 104.99M | $ 106.82M | $ 77.77M | $ 71.63M | $ 57.67M |
| Stockholders' Equity | $ 3.06M | $ -16.37M | $ -40.82M | $ -42.29M | $ -13.37M |
| Cash Flow | |||||
| Free Cash Flow | $ -26.60M | $ 17.80M | $ -13.11M | $ -22.03M | $ -23.34M |
| Operating Cash Flow | $ -24.55M | $ 19.46M | $ -11.92M | $ -21.00M | $ -21.36M |
| Investing Cash Flow | $ -10.51M | $ -13.21M | $ -613.00K | $ 1.30M | $ -316.00K |
| Financing Cash Flow | $ 38.82M | $ 33.32M | $ 25.53M | $ 1.56M | $ -800.00K |
Currency in EUR
